📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
1,000+ announcements match the current filters (relevance ≥ 5).
3rd CoC Meeting Scheduled for Aug 10 as India Power Corp (DPSCLTD) Undergoes Insolvency
DPSC Limited (India Power Corporation Limited) is currently undergoing the Corporate Insolvency Resolution Process (CIRP) following an NCLT Hyderabad Bench-I order dated May 15, 2026. The company has scheduled the 3rd meeting of the Committee of Creditors (CoC) for August 10, 2026, to discuss the resolution process. Despite a TTM revenue of ₹683 Cr and a net worth of ₹650 Cr, the company's management is now under the authority of a Resolution Professional (RP). Equity investors face significant risk as the insolvency process prioritizes creditor recovery.
Confidence: HIGH
What changedThe company has progressed to the third meeting of its creditors under the formal insolvency framework initiated in May 2026.
Why it mattersThe CIRP process determines the survival of the company; the CoC will decide whether to accept a resolution plan from a new investor or proceed toward liquidation.
NCLT Order Date: 15th May, 2026CoC Meeting Date: 10th August, 2026Debt to Equity Ratio: 0.18TTM Revenue: ₹683 CrMarket Cap: ₹729 Cr
📅 Short termExpect continued volatility and downward pressure as the insolvency process unfolds and the Resolution Professional manages operations.
📈 Long termThe long-term outlook is entirely dependent on the NCLT-approved resolution plan; equity holders often face severe dilution in such restructurings.
⚠ Risk flags
- Corporate Insolvency Resolution Process (CIRP)
- Potential total loss of equity value
- Management control shifted to Resolution Professional
- High regulatory sensitivity
Key Highlights
CIRP initiated by Hon'ble NCLT, Hyderabad Bench-I, via order dated 15th May, 2026
3rd Meeting of the Committee of Creditors (CoC) scheduled for 10th August, 2026, at 3:00 P.M.
Company reported TTM revenue of ₹683 Cr and a thin PAT of ₹13 Cr
Debt stands at ₹119 Cr against a market capitalization of ₹729 Cr
Stock has seen a 12-month price return of -37.0% amid financial and regulatory stress
👀 What to Watch
Investors should closely monitor the outcomes of CoC meetings for any proposed resolution plans or potential liquidation risks, as equity value is typically at high risk during CIRP.
Gloster Ltd Approves 200% Dividend (Rs 20/Share) at 104th AGM
Gloster Limited concluded its 104th Annual General Meeting on August 7, 2026, where shareholders approved a final dividend of 200% (Rs 20 per share). The total dividend payout of approximately Rs 21.88 Cr is notable as it exceeds the company's FY26 PAT of Rs 18.14 Cr, indicating a distribution from accumulated reserves. Shareholders also ratified the appointment of M/s Singhi & Co. as Statutory Auditors and the reappointment of Chairman Hemant Bangur. All resolutions were passed with a near-unanimous majority of over 99.99%.
Confidence: HIGH
What changedThe company has formally ratified its FY26 financial performance and confirmed the dividend distribution to shareholders.
Why it mattersThe approval confirms a significant cash outflow for dividends and ensures management continuity, while the high payout ratio suggests a commitment to returning capital despite modest annual earnings.
Final Dividend: Rs 20 per shareDividend Payout vs FY26 PAT: ~120.6%Record Date: 31-07-2026Total Shares Polled: 91,99,322FY26 Revenue: Rs 1426.73 Cr
📅 Short termThe stock may see minor adjustments post-AGM as the dividend payment process initiates; the record date of July 31, 2026, has already passed.
📈 Long termLimited structural impact from this routine meeting, though the high dividend payout and ongoing diversification into industrial cables remain key long-term themes.
⚠ Risk flags
- Dividend payout exceeds annual net profit
- Regulatory risks regarding Jute Packaging Materials Act (JPMA) norms
Key Highlights
Approved a final dividend of 200%, equivalent to Rs 20 per equity share of Rs 10 face value.
Total dividend payout of ~Rs 21.88 Cr exceeds the FY26 Net Profit of Rs 18.14 Cr.
Shareholders passed the adoption of FY26 Audited Financial Statements with 9,199,299 votes in favour.
Reappointed Shri Hemant Bangur as Director and appointed M/s Singhi & Co. as Statutory Auditors.
The meeting saw participation from 42 shareholders via video conferencing, representing 84.06% of outstanding shares.
👀 What to Watch
Monitor the company's cash flow management given the high dividend payout relative to annual profits, and track the execution of the 19% jute capacity expansion to 300 TPD.
66% PAT Growth in Q1 FY27; GPT Healthcare Reports 18.2% Revenue Increase
GPT Healthcare reported a strong Q1 FY27 with total income rising 18.2% and PAT surging 66% YoY. While overall network occupancy stood at 45.5%, mature hospitals maintained a healthier 58.07%, reflecting the initial ramp-up phase of the newly commissioned Raipur facility which reached 17% occupancy. ARPOB improved to ₹42,350, driven by a shift toward high-end tertiary care and robotic surgeries. Management expects the Dumdum facility to reach 70% occupancy by Q3 FY27 and is targeting approximately 10 liver transplants annually at the Raipur unit.
Confidence: HIGH
What changedThe company has transitioned from a pure capacity addition phase to an operational ramp-up phase, specifically showing traction in robotic surgeries and organ transplants.
Why it mattersThe significant jump in PAT relative to revenue suggests improving operational leverage and a better case mix, which is critical for a mid-sized hospital chain to improve its 16.8% OPM.
PAT Growth (YoY): 66%Revenue Growth (YoY): 18.2%Network ARPOB: ₹42,350Cash and Insurance Payer Mix: 90%Raipur Occupancy: 17%Mature Hospital Occupancy: 58.07%
📅 Short termThe stock may see positive interest due to the high PAT growth and successful clinical milestones like the first liver transplant in Raipur.
📈 Long termLong-term value depends on the Raipur facility reaching monthly breakeven (expected by month 13-14) and the successful commissioning of the Ranchi unit in FY28.
⚠ Risk flags
- Low occupancy at the new Raipur unit (17%) acting as a drag on overall margins
- Geographic concentration in West Bengal and Tripura
- Geopolitical issues impacting patient inflow from Bangladesh at the Agartala unit
Key Highlights
PAT increased by 66% YoY during Q1 FY27, significantly outpacing revenue growth.
Total income grew by 18.2% YoY, supported by a 31% revenue jump at the Howrah facility.
Average Revenue Per Occupied Bed (ARPOB) improved to ₹42,350 across the network.
Mature hospital occupancy (excluding Raipur) remained steady at 58.07%.
Raipur facility achieved NABH accreditation in a record 13 months with occupancy rising to 17% from 7% YoY.
👀 What to Watch
Monitor the occupancy ramp-up at the Raipur facility and the management's ability to sustain ARPOB growth through complex surgeries. Investors should also track the execution timeline for the Ranchi hospital planned for FY28.
47% Y-o-Y Revenue Growth for HealthX as Gross Margins Expand to 7.9%
HealthX Platform Limited (formerly Sastasundar Ventures) reported a strong 47% Y-o-Y revenue growth for the June 2026 quarter, with top-line momentum across all channels. Gross margins improved by 130 bps Y-o-Y to 7.9%, driven by better sourcing and a higher private-label mix. The company has successfully transitioned back to 100% ownership of the SastaSundar platform following the exit of Flipkart Health+ as an associate in FY25. While the company remains near break-even with an FY26 PAT of Rs -1.4 cr, it maintains a lean working capital cycle of 28 days.
Confidence: HIGH
What changedThe company has moved from a 25% minority stake in its core platform back to 100% ownership and is reporting accelerated growth post-restructuring.
Why it mattersRegaining full control allows HealthX to execute its AI-powered digital health strategy without external partner constraints, though it must now fund its own scaling and infrastructure.
Revenue (Q1 FY27): Rs 459.7 crY-o-Y Revenue Growth: 47%Gross Margin (June-26): 7.9%Working Capital Days: 28 daysRetailer Shakti CAGR: 96%
📅 Short termThe strong quarterly growth and margin expansion are likely to be viewed positively by the market in the coming weeks.
📈 Long termThe structural shift to 100% ownership and an asset-light model provides a long-term runway for scaling, provided the company can achieve sustainable PAT margins.
⚠ Risk flags
- Historical volatility in growth during partnership transitions
- Current near-break-even profitability
- High competition in the digital pharmacy and healthcare distribution space
Key Highlights
Revenue grew 47% Y-o-Y and 16% Q-o-Q for the quarter ended June 2026.
Gross Margin expanded by 130 bps Y-o-Y to reach 7.9% in the current quarter.
Retailer Shakti platform achieved a 96% CAGR from FY20 to FY26, with sales reaching Rs 1,125 cr.
Net working capital cycle improved to 28 days, representing an 11% Y-o-Y reduction.
The company regained 100% operational control of SastaSundar after the Flipkart partnership ended in FY25.
👀 What to Watch
Investors should monitor the company's ability to convert high top-line growth into bottom-line profitability now that it has full operational control. Key metrics to watch include the continued expansion of gross margins and the absorption of fixed costs through operating leverage.
Sejal Glass Q1 FY27 Consolidated Revenue Grows 52.9% YoY to ₹117.95 Cr
Sejal Glass Limited submitted a machine-readable copy of its Q1 FY27 results following an NSE query. The company reported a consolidated revenue of ₹117.95 Cr for the quarter ended June 30, 2026, representing a 52.9% increase over the ₹77.15 Cr reported in the same quarter last year. Consolidated Net Profit rose to ₹7.22 Cr from ₹4.42 Cr in Q1 FY26. The results are not directly comparable to the previous year due to the acquisition of the Glasstech business in April 2025.
Confidence: HIGH
What changedThe company re-submitted its Q1 FY27 financial results in a machine-readable format as per NSE compliance requirements.
Why it mattersThe filing confirms strong growth momentum following the Glasstech acquisition and highlights the company's heavy reliance on international markets (70%+ of revenue).
Consolidated Revenue (Q1 FY27): ₹117.95 CrConsolidated PAT (Q1 FY27): ₹7.22 CrInternational Revenue Share: 70.8%Q1 Revenue vs TTM Revenue: 29.7%Consolidated EPS (Q1 FY27): ₹6.27
📅 Short termThe results show strong operational performance; however, as this is a re-submission of previously known data, the immediate market impact may be limited.
📈 Long termThe successful integration of value-added glass segments and expansion in the UAE market are structural positives for long-term growth.
⚠ Risk flags
- High revenue concentration in international markets (70.8%)
- Geopolitical risks in the GCC region affecting the UAE subsidiary
- Non-comparability of results due to Glasstech acquisition
Key Highlights
Consolidated Revenue for Q1 FY27 reached ₹117.95 Cr, up from ₹77.15 Cr in Q1 FY26.
Consolidated Net Profit increased to ₹7.22 Cr, a 63.5% growth compared to ₹4.42 Cr in the year-ago period.
International operations contributed ₹83.59 Cr, accounting for 70.8% of total consolidated revenue.
Standalone revenue stood at ₹36.43 Cr with a net profit of ₹0.40 Cr for the quarter.
The company noted no provision for tax in standalone results due to carried forward losses and unabsorbed depreciation.
👀 What to Watch
Investors should monitor the margin contribution from the newly acquired Glasstech business and the stability of the UAE subsidiary, which remains the primary revenue driver.
Q1 FY27 Standalone Net Profit Surges 158% YoY to ₹13.88 Cr
Gloster Limited reported a robust performance for Q1 FY27, with standalone revenue growing 42.7% YoY to ₹242.86 Cr. Standalone Net Profit saw a significant jump of 158% to ₹13.88 Cr from ₹5.38 Cr in Q1 FY26. The consolidated results highlight the growing importance of the 'Cables & Other Electrical Products' segment, which contributed ₹79.26 Cr to the total consolidated revenue of ₹204.56 Cr. The company is also awaiting NCLT approval for the amalgamation of two subsidiaries.
Confidence: HIGH
What changedThe company delivered a strong quarterly earnings beat with significant YoY growth in both revenue and net profit.
Why it mattersThe results validate the company's diversification strategy into industrial cables, which now provides a substantial secondary revenue stream alongside its 100-year-old jute business.
Standalone Revenue (Q1 FY27): ₹242.86 CrStandalone Net Profit (Q1 FY27): ₹13.88 CrCables Segment Revenue: ₹79.26 CrGoodwill Amortization (Net): ₹141.66 CrRevenue vs TTM Revenue: ~17%
📅 Short termThe stock is likely to see positive momentum in the coming days as the market digests the strong triple-digit profit growth.
📈 Long termThe structural shift from a pure-play jute company to a diversified industrial entity (Cables + Jute) improves the long-term risk profile and growth potential.
⚠ Risk flags
- Ongoing trademark litigation for the 'Gloster' brand
- Regulatory dependency on Jute Packaging Materials Act (JPMA) norms
- Pending NCLT approval for corporate restructuring
Key Highlights
Standalone Revenue from operations rose 42.7% YoY to ₹242.86 Cr vs ₹170.19 Cr in Q1 FY26
Standalone Net Profit increased 158% YoY to ₹13.88 Cr from ₹5.38 Cr
Cables segment revenue reached ₹79.26 Cr, contributing significantly to the consolidated top line
Amortization of goodwill totaling ₹141.66 Cr is being processed as per NCLT orders dated January 2018
Amalgamation of Gloster Lifestyle and Gloster Specialities is pending final NCLT approval after being reserved for order on Feb 14, 2026
👀 What to Watch
Monitor the final NCLT order regarding the subsidiary amalgamation and track the execution of the ₹1,200 Cr cable order book mentioned in previous filings to see if margins sustain.
₹80 Cr Fundraise via Warrants and Increase in Authorized Capital to ₹79 Cr
Rollatainers Limited has scheduled an Extraordinary General Meeting (EGM) on August 31, 2026, to seek approval for a ₹80 crore fundraise through the issuance of 35.87 crore convertible warrants. The warrants are priced at ₹2.23 each, which is a discount to the current market price of ₹3.1. This capital infusion is highly material as it exceeds the company's current market capitalization of ₹77 crore. Additionally, the company is seeking a massive ₹1,000 crore limit for inter-corporate loans and investments, signaling a potential pivot or major acquisition strategy following its recent disinvestment of its primary subsidiary.
Confidence: HIGH
What changedThe company is moving from a post-divestment shell-like state (zero revenue) to a capitalized entity by raising ₹80 crore and expanding its legal capacity to invest up to ₹1,000 crore.
Why it mattersThis is a survival and restart event; the capital raised is larger than the company's entire current market value, suggesting a complete restructuring or entry into a new business line.
Fundraise Amount: ₹80 CrFundraise vs Market Cap: 103.9%Warrant Issue Price: ₹2.23Proposed Investment Limit: ₹1,000 CrNew Authorized Capital: ₹79 Cr
📅 Short termThe stock may react to the significant capital infusion and the entry of new non-promoter investors, though the warrant price is below the current market price.
📈 Long termThe long-term outlook depends entirely on how the ₹80 crore is deployed, as the previous core packaging business has been discontinued.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Significant equity dilution
- Zero current operational revenue
- Material uncertainty regarding going concern status
- High investment limit (₹1,000 Cr) relative to current scale
Key Highlights
Issuance of up to 35,87,44,394 convertible equity warrants at ₹2.23 per warrant to promoters and non-promoters.
Total fundraise of up to ₹80 crore, representing approximately 104% of the current market capitalization.
Increase in Authorized Share Capital from ₹65 crore to ₹79 crore to accommodate the new issuance.
Proposed Section 186 limit of ₹1,000 crore for loans, guarantees, and investments, which is over 100x the current net worth of ₹9 crore.
Appointment of Sunil Kumar Sharma as Managing Director and Vipul Gupta as Independent Director.
👀 What to Watch
Investors should monitor the EGM outcome on August 31, 2026, and specifically look for disclosures regarding the 'use of proceeds' for the ₹80 crore, as the company currently reports zero operational revenue.
Health X Platform Reports Q1 Net Loss of ₹51.43 Lakhs; Revenue Declines 17% YoY
Health X Platform Limited (formerly Sastasundar Ventures) reported a standalone net loss of ₹51.43 lakhs for the quarter ended June 30, 2026, compared to a loss of ₹10.95 lakhs in the same period last year. Revenue from operations fell to ₹8.00 lakhs from ₹9.67 lakhs YoY, while total expenses surged to ₹60.72 lakhs. The company is currently undergoing a composite scheme of arrangement and amalgamation with Microsec Resources Private Limited, which is pending regulatory approval. Additionally, the board approved the re-appointment of Mrs. Anjana Dikshit as an Independent Director for a second five-year term.
Confidence: HIGH
What changedThe company reported a widening quarterly loss and confirmed the re-appointment of an Independent Director while providing an update on its pending corporate restructuring.
Why it mattersThe widening losses and low revenue base indicate significant operational stress; the pending merger/demerger scheme is the key structural event that could redefine the company's business model.
Revenue from Operations (Q1): ₹8.00 LakhsNet Loss (Q1): ₹51.43 LakhsTotal Expenses (Q1): ₹60.72 LakhsOther Expenses (Q1): ₹50.30 LakhsIndependent Director Term: 5 years
📅 Short termThe stock may face downward pressure due to the widening losses and weak operational revenue reported for the June quarter.
📈 Long termThe long-term trajectory depends on the successful execution of the restructuring scheme and the ability of the healthcare segment to achieve operational break-even.
⚠ Risk flags
- Operational losses in step-down subsidiary Genu Path Labs Limited
- Significant widening of standalone net loss
- High 'Other Expenses' relative to total revenue
Key Highlights
Standalone net loss widened significantly to ₹51.43 lakhs in Q1 FY27 from ₹10.95 lakhs in Q1 FY26.
Revenue from operations decreased by 17.3% YoY to ₹8.00 lakhs.
Total expenses increased to ₹60.72 lakhs, primarily driven by 'Other Expenses' amounting to ₹50.30 lakhs.
Re-appointment of Mrs. Anjana Dikshit as Independent Director for a 5-year term starting November 10, 2026.
A composite scheme of arrangement with Microsec Resources Private Limited is pending, with an appointed date of April 01, 2026.
👀 What to Watch
Investors should monitor the regulatory approval timeline for the 'Composite Scheme of Arrangement' and the operational performance of the 'Healthcare Network' segment, which has been facing losses.
CRISIL Reaffirms 'A/Stable' Rating; Assigns 'A/Stable' to Rs 100 Cr Bank Debt
CRISIL has reaffirmed Midwest Limited's corporate credit rating at 'CRISIL A/Stable' and assigned the same to its Rs 100 crore bank loan facilities. The company's financial profile is supported by a strong net worth of over Rs 845 crore as of March 2026, significantly enhanced by a recent Rs 250 crore IPO. While Midwest holds a dominant 55% market share in India's Black Galaxy granite exports, it faces product concentration risk with 69% of FY26 revenue derived from this single segment. Liquidity remains strong with projected annual cash accruals exceeding Rs 150 crore against debt obligations of approximately Rs 30 crore.
Confidence: HIGH
What changedCRISIL has assigned new ratings to the company's bank debt and reaffirmed its existing corporate credit rating, reflecting a stable financial outlook post-IPO.
Why it mattersThe rating confirms the company's strong liquidity and capital structure, which are essential for funding its diversification into high-tech materials like Quartz and Heavy Mineral Sands for aerospace and defense.
Bank Loan Facilities Rated: Rs 100 CroreAdjusted Net Worth (Mar 2026): Rs 845 croreIPO Proceeds: Rs 250 croreBlack Galaxy Revenue Share: 69%Expected Annual Accruals: > Rs 150 croreInterest Coverage Ratio: > 10x
📅 Short termThe rating reaffirmation is expected to maintain investor confidence in the company's credit profile following its recent listing.
📈 Long termThe 'Stable' outlook hinges on the company's ability to successfully diversify its product mix and maintain margins amid global cyclicality in real estate and construction.
⚠ Risk flags
- High product concentration (69% revenue from Black Galaxy granite)
- Vulnerability to foreign exchange rate fluctuations
- Susceptibility to regulatory changes in mining royalties and export duties
Key Highlights
CRISIL assigned 'A/Stable' and 'A1' ratings to Rs 100 crore of total bank loan facilities.
Adjusted net worth reached over Rs 845 crore as of March 31, 2026, following a Rs 250 crore IPO.
Black Galaxy granite segment contributed approximately 69% to consolidated revenue in fiscal 2026.
Annual cash accruals are expected to exceed Rs 150 crore against yearly debt obligations of ~Rs 30 crore.
Interest coverage ratio is projected to remain healthy at above 10 times over the medium term.
👀 What to Watch
Monitor the execution and ramp-up of Quartz Phase 2 and the commencement of Heavy Mineral Sands (HMS) operations in FY27 to evaluate the company's progress in reducing its 69% revenue dependence on Black Galaxy granite.
PNB Gilts Sets Sep 21 as Record Date for Dividend; Appoints PNB ED to Board
PNB Gilts has fixed September 21, 2026, as the record date for its final dividend for FY 2025-26, subject to shareholder approval at the upcoming AGM on September 28, 2026. The board also appointed Sh. Amit Kumar Srivastava, an Executive Director at parent Punjab National Bank (PNB), as a Non-Executive Director. Srivastava brings over 31 years of banking experience, including a tenure as Group Chief Risk Officer at PNB. The dividend, if approved, will be paid within 30 days of the AGM.
Confidence: HIGH
What changedThe company has established the timeline for its annual dividend payout and updated its board composition with a nominee from its promoter, Punjab National Bank.
Why it mattersThe appointment ensures continued strategic alignment and oversight from the parent bank (74.1% holder), while the record date provides clarity on shareholder returns for the fiscal year.
Record Date: 21-Sep-2026AGM Date: 28-Sep-2026Promoter Holding: 74.1%TTM PAT: Rs 182 Cr
📅 Short termThe stock may see routine activity around the record date as investors position for the dividend; the board appointment reinforces parent-subsidiary ties.
📈 Long termLimited structural impact as these are routine governance and capital distribution activities for a PNB subsidiary.
⚠ Risk flags
- Director appointment is subject to RBI and shareholder approval
Key Highlights
Record date for FY 2025-26 final dividend fixed for September 21, 2026
30th Annual General Meeting scheduled for September 28, 2026, at 11:00 AM
Appointment of Sh. Amit Kumar Srivastava (ED, PNB) as Non-Executive Director
Dividend payment to be completed within 30 days of the AGM declaration
New director brings 31 years of banking experience across various verticals
👀 What to Watch
Investors should note the record date of September 21 for dividend eligibility and monitor the AGM outcome on September 28 for final approval.
PNB Gilts Sets Sept 21 Record Date for Dividend; Appoints PNB Executive Director to Board
PNB Gilts has scheduled its 30th Annual General Meeting (AGM) for September 28, 2026, and fixed September 21, 2026, as the record date for the final dividend of FY 2025-26. The board also approved the appointment of Sh. Amit Kumar Srivastava, currently an Executive Director at parent Punjab National Bank (PNB), as a Non-Executive Director, subject to RBI and shareholder approval. This move strengthens the leadership link with PNB, which provides critical liquidity support including a Rs 2,100 Cr intraday facility. The company continues to operate with a strong net worth of Rs 1,710 Cr as of the latest filings.
Confidence: HIGH
What changedThe company has formalized the timeline for its annual dividend payout and proposed a board-level change to include a senior executive from its parent bank.
Why it mattersThe appointment of a PNB Executive Director to the board ensures continued strategic alignment with the parent bank, which is vital given the company's reliance on PNB for liquidity and its high sensitivity to interest rate movements.
Record Date: September 21, 2026AGM Date: September 28, 2026Promoter Holding: 74.07%TTM PAT: Rs 182 CrNet Worth: Rs 1710 Cr
📅 Short termThe stock may experience routine price adjustments around the ex-dividend date following the September 21 record date.
📈 Long termLimited structural impact; the board appointment is standard for a subsidiary, though the appointee's risk management background aligns with the company's volatile G-Sec trading profile.
Key Highlights
Record date for the final dividend of FY 2025-26 is fixed as September 21, 2026.
30th Annual General Meeting (AGM) to be held on September 28, 2026, via VC/OAVM.
Appointment of Sh. Amit Kumar Srivastava (ED of PNB) as Non-Executive Director, bringing 31 years of banking experience.
Parent PNB maintains a 74.07% promoter stake in the company.
Dividend payment to be completed within 30 days of declaration at the AGM.
👀 What to Watch
Investors should note the September 21 record date for dividend eligibility and monitor the AGM on September 28 for updates on the company's diversification into forex operations.
Subex Q1 FY27: 19.7% YoY Revenue Growth and 21.2% EBITDA Margin Reported
Subex reported a strong start to FY27, with revenue growing 19.7% YoY and 8.9% sequentially, signaling a transition from its turnaround phase to sustainable growth. The company achieved a significant EBITDA margin of 21.2%, driven by improved operational discipline and execution of the order backlog. Cash reserves remain robust at Rs 184.8 Cr, providing a strong buffer for planned investments in AI and product innovation. Management highlighted a focus on the Partner Ecosystem Management (PEM) segment, which is seeing increased deal flow and renewals.
Confidence: HIGH
What changedSubex has officially moved from a 'turnaround' phase to a 'growth' phase, characterized by consistent profitability and double-digit YoY revenue growth.
Why it mattersAfter reporting losses in FY24 and FY25, the company's return to high margins and strong cash generation validates its restructuring strategy and improves its financial stability.
Q1 FY27 Revenue Growth (YoY): 19.7%EBITDA Margin: 21.2%Cash and Equivalents: Rs 184.8 CrRecurring Revenue: ~70%Forex Gain Impact (QoQ): ~Rs 3 Cr
📅 Short termThe stock may see positive sentiment due to the sharp recovery in margins and the management's confident outlook on the growth phase.
📈 Long termThe structural shift towards AI-led products and diversification into non-telecom sectors could re-rate the business if execution remains consistent over the next 4-6 quarters.
⚠ Risk flags
- High client concentration (95% revenue from Telecom)
- Intense competition in the software application industry
- Potential margin compression from planned growth investments
Key Highlights
Revenue grew 19.7% YoY and 8.9% sequentially in Q1 FY27, reaching approximately Rs 79 Cr.
EBITDA margin expanded to 21.2%, representing a fourfold increase in absolute EBITDA compared to Q1 FY26.
Cash and cash equivalents stood at Rs 184.8 Cr as of June 30, 2026, strengthening the balance sheet.
Forex gains contributed approximately Rs 3 Cr to the sequential revenue increase from Rs 72 Cr to Rs 79 Cr.
Recurring revenue remains stable at approximately 70% of the total revenue mix.
👀 What to Watch
Monitor the sustainability of the 21% EBITDA margin in upcoming quarters as management plans to reinvest profits into AI and customer-facing teams. Watch for updates on the new product roadmap for BFSI sectors to reduce the 95% telecom concentration.
77% Revenue Growth in Q1 FY27 as Viceroy Hotels Targets 30% EBITDA Margin
Viceroy Hotels reported a robust Q1 FY27 with consolidated revenue jumping 77% YoY to ‑44.9 cr, driven by the integration of Marriott Executive Apartments and renovated capacity. EBITDA margins expanded to 26.3% from 19% YoY, although PAT remained thin at ‑1.4 cr due to finance costs surging to ‑5.4 cr following the ‑206 cr SLN Terminus acquisition. Management has guided for a 30% EBITDA margin for FY27, banking on the return of the Marriott Convention Center in Phase 2. Operational metrics showed strength with combined occupancy rising to 76.25% from 53.65%.
Confidence: HIGH
What changedThe company has successfully integrated the SLN Terminus acquisition and completed Phase 1 renovations, leading to a significant jump in operational scale and a shift from loss to profit.
Why it mattersThe operational turnaround and high-occupancy levels (76%+) indicate strong demand in the Hyderabad market, which is critical to servicing the company's increased debt load of ‑223 cr.
Q1 FY27 Revenue: ‑44.9 crEBITDA Margin: 26.3%Finance Cost (Q1): ‑5.4 crAcquisition Value vs TTM Revenue: ~135%Combined Occupancy: 76.25%
📅 Short termThe market is likely to react positively to the 77% revenue growth and operational turnaround, though the high interest burden remains a point of caution.
📈 Long termThe shift towards high-ADR executive apartments and modernized assets could structurally re-rate the business if the 40% long-term EBITDA margin target is approached.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- High financial leverage (gearing 6.23x)
- Significant increase in finance costs
- Cyclicality of the hospitality industry
Key Highlights
Consolidated revenue grew 77% YoY to ‑44.9 cr in Q1 FY27.
EBITDA increased 144% YoY to ‑11.8 cr with margins expanding by 725 basis points.
Finance costs rose sharply to ‑5.4 cr from ‑1 cr YoY due to acquisition-related debt.
Courtyard RevPAR nearly doubled to ‑5,006 from ‑2,545 following Phase 1 renovation completion.
Marriott Executive Apartments achieved 94% occupancy with a high ADR of ‑13,342.
👀 What to Watch
Watch for the completion of Phase 2 renovations (Convention Center) which is expected to boost high-margin banqueting revenue, and monitor if the company can sustain the 30% EBITDA margin target despite high interest outflows.
₹5,000-10,000 Cr Major Offshore Order Win from ONGC
L&T Energy Hydrocarbon (LTEH) has secured 'Major' offshore contracts from ONGC for projects off India's west coast. The scope includes the Pipeline Replacement Project (PRP-X) and the EPCIC of four Well Head Platforms. Valued between ₹5,000 Cr and ₹10,000 Cr, this win represents approximately 1.7% to 3.5% of L&T's TTM revenue of ₹2,85,874 Cr. This order adds to an already robust order book of ₹6,67,041 Cr (as of Sept 2025), providing strong medium-term revenue visibility.
Confidence: HIGH
What changedL&T has secured a significant domestic offshore energy contract from ONGC, expanding its hydrocarbon project backlog.
Why it mattersThe win reinforces L&T's leadership in the high-tech offshore EPCIC space and supports its 15% annual growth target by utilizing its in-house fabrication and marine fleet capabilities.
Order Value Range: ₹5,000 to ₹10,000 CrOrder vs TTM Revenue: 1.75% to 3.50%Well Head Platforms: 4 unitsTTM Revenue: ₹2,85,874 CrOrder Book (Sept 2025): ₹6,67,041 Cr
📅 Short termPositive sentiment expected as the order confirms steady deal flow from domestic oil majors, supporting the infrastructure-heavy H2 execution cycle.
📈 Long termStrengthens the Energy Hydrocarbon division's portfolio; critical for maintaining the order book-to-sales ratio and long-term revenue growth.
⚠ Risk flags
- Execution risks in complex offshore environments
- Potential for cost overruns in fixed-price EPCIC contracts
- Dependence on ONGC's project timelines
Key Highlights
Order value classified as 'Major', ranging between ₹5,000 Cr and ₹10,000 Cr
Project involves EPCIC of 4 Well Head Platforms and multiple subsea pipeline segments
Client is ONGC, a key National Oil Company with strong cash flows
Order contributes to the Hydrocarbon segment's growth strategy in the offshore energy infrastructure space
L&T's total order book stood at ₹6.67 trillion as of September 2025
👀 What to Watch
Watch for execution timelines and margin performance in the Energy segment, as management previously noted 'soft' margins in this division due to cost overruns in competitive projects.
1:1 Bonus Issue: Ideal Technoplast to Capitalize ₹5 Cr and Increase Authorized Capital
Ideal Technoplast has convened its 3rd AGM for August 31, 2026, to seek shareholder approval for a 1:1 bonus issue. The company intends to capitalize ₹5 crore from its surplus to issue 50,00,000 new equity shares of ₹10 each. To accommodate this issuance, the authorized share capital is proposed to increase from ₹5 crore to ₹12 crore. This corporate action follows a reported net profit of ₹1.80 crore in the March 2026 quarter and aligns with the company's ongoing capacity expansion at its Surat facility.
Confidence: HIGH
What changedThe company is doubling its outstanding shares via a 1:1 bonus issue and increasing its authorized capital limit by 140%.
Why it mattersThe bonus issue improves stock liquidity and signals management's confidence in the company's reserves and future growth prospects as it expands production capacity.
Bonus Ratio: 1:1Capitalization Amount: ₹5.00 CrNew Authorized Capital: ₹12.00 CrCapitalization vs Net Worth: ~18.5%AGM Date: August 31, 2026
📅 Short termThe announcement is likely to generate positive sentiment and increased trading volume leading up to the AGM and the eventual record date.
📈 Long termWhile the bonus issue is a capital restructuring, it reflects a larger equity base to support the company's expansion into export markets and its new 92,500 sq ft Surat facility.
⚠ Risk flags
- EPS dilution due to increased share count
- Raw material price volatility impacting margins
Key Highlights
Proposed 1:1 Bonus Issue (one new share for every one existing share held)
Capitalization of ₹5,00,00,000 from the company's surplus for the bonus issue
Increase in Authorized Share Capital from ₹5,00,00,000 to ₹12,00,00,000
AGM scheduled for August 31, 2026, at 04:00 PM via Video Conferencing
Issuance of 50,00,000 new equity shares of ₹10 each post-approval
👀 What to Watch
Monitor the AGM outcome on August 31, 2026, and the subsequent announcement of the Record Date for the bonus allotment.
Rs 80 Cr Fundraise: Rollatainers to Issue 35.87 Cr Warrants at Rs 2.23 Each
Rollatainers Limited has announced a massive preferential issue of 35.87 crore convertible warrants to raise up to Rs 80 crore. The warrants are priced at Rs 2.23 each, which is a discount to the current market price of Rs 3.0. This capital infusion is highly significant as it exceeds the company's current market capitalization of Rs 73 crore and its net worth of Rs 9 crore. The funds are being raised from 17 allottees, including four promoter group entities who will take up approximately 47.5% of the issue.
Confidence: HIGH
What changedThe company has detailed a specific plan to raise Rs 80 crore via warrants, identifying 17 specific investors and setting a conversion price of Rs 2.23.
Why it mattersThis is a survival-critical event; the fundraise is ~110% of the company's current market cap and is essential to address the 'going concern' uncertainty and accumulated losses of Rs 123.6 crore.
Total Fundraise Value: Rs 80 crFundraise vs Market Cap: 109.6%Warrant Issue Price: Rs 2.23Total Warrants to be Allotted: 35,87,44,394Promoter Group Allotment: 17,04,04,588 warrants
📅 Short termThe stock may see volatility as the market digests the massive equity dilution versus the much-needed liquidity injection at a price below current market value.
📈 Long termThe long-term viability depends entirely on management's ability to deploy this Rs 80 crore into revenue-generating assets following the disinvestment of its primary subsidiary in 2025.
⚠ Risk flags
- Significant equity dilution
- Issue price below current market price
- History of zero revenue in recent quarters
- Material uncertainty regarding going concern status
Key Highlights
Total fundraise of up to Rs 80 crore through preferential allotment of warrants
Issuance of 35,87,44,394 warrants convertible into equity shares within 18 months
Issue price fixed at Rs 2.23 per warrant, including a premium of Rs 1.23
17 proposed allottees including 4 promoter entities and 13 non-promoter entities
Post-conversion, Amzen Financial Services (Promoter) will hold a 16.20% stake on a fully diluted basis
👀 What to Watch
Investors should monitor the upcoming Extraordinary General Meeting (EGM) for shareholder approval and watch for specific disclosures on how the Rs 80 crore will be utilized to restart operations, given the current zero-revenue status.
₹80 Cr Fundraise: Rollatainers to Issue 35.87 Cr Warrants at ₹2.23 Each
Rollatainers Limited has announced a corrigendum regarding its board's decision to raise up to ₹80 crore through the preferential issuance of 35,87,44,394 convertible equity warrants. The warrants are priced at ₹2.23 each (including a ₹1.23 premium), representing a discount to the current market price of ₹3.0. This fundraise is highly significant as it exceeds the company's current market capitalization of ₹73 crore and aims to address a severely eroded net worth of ₹9 crore and accumulated losses of ₹123.61 crore. The issuance involves 17 allottees, including four promoter entities and 13 non-promoter entities.
Confidence: HIGH
What changedThe company issued a corrigendum to clarify the specific details and list of 17 allottees for its proposed ₹80 crore preferential warrant issue.
Why it mattersThis is a survival-level event for the company; the capital infusion is larger than its entire market cap and is necessary to address 'going concern' risks and a negative ROCE of -3.5%.
Total Fundraise Value: ₹80 crFundraise vs Market Cap: 109.6%Issue Price per Warrant: ₹2.23Total Warrants to be Allotted: 35,87,44,394Post-Issue Promoter Group Shareholding (Diluted): 27.98%
📅 Short termThe stock may see volatility as the market digests the significant equity dilution and the discount of the issue price relative to the current market price.
📈 Long termThe long-term viability depends entirely on the company's ability to utilize these funds to generate revenue, which has been at zero for the past several quarters following the sale of its main subsidiary.
⚠ Risk flags
- Massive equity dilution from 35.87 crore new shares
- Issue price is at a discount to current market price
- Company currently reports zero operational revenue
- Material uncertainty regarding 'going concern' status
Key Highlights
Proposed issuance of 35,87,44,394 convertible equity warrants at ₹2.23 per warrant.
Total fundraise value capped at ₹80 crore, which is approximately 109% of the current market cap.
Warrants are convertible into equity shares within a period of 18 months from the date of allotment.
Participation from 17 investors, including promoter entities like Amzen Financial Services (16.20% post-dilution).
Issue price of ₹2.23 is at a ~25% discount to the current market price of ₹3.0.
👀 What to Watch
Investors should monitor the upcoming Extraordinary General Meeting (EGM) for shareholder approval and subsequent regulatory clearances. The key factor to watch is the management's plan for deploying this ₹80 crore, specifically whether it will be used to restart operations given the current zero-revenue status.
GPT Healthcare Declares ₹1.50 Final Dividend at 37th AGM; Total FY26 Dividend at ₹2.50
GPT Healthcare concluded its 37th Annual General Meeting on August 6, 2026, where shareholders approved a final dividend of ₹1.50 per share. This brings the total dividend for FY25-26 to ₹2.50 per share, which is notable given the FY26 EPS of ₹2.08. The meeting also covered the adoption of FY26 audited financials (Revenue: ₹227.27 Cr, PAT: ₹17.05 Cr) and the re-appointment of several directors. Additionally, shareholders considered resolutions for remuneration and consultancy fees for three related-party medical professionals.
Confidence: HIGH
What changedThe company has finalized its dividend distribution for FY26 and obtained shareholder approval for its annual financial accounts and board composition.
Why it mattersThe total dividend of ₹2.50 per share represents a high payout ratio relative to the FY26 EPS of ₹2.08, signaling a strong commitment to returning cash to shareholders despite ongoing expansion plans in Raipur and Ranchi.
Final Dividend: ₹1.50 per shareTotal FY26 Dividend: ₹2.50 per shareDividend vs FY26 EPS: 120.19%Shareholder Attendance: 65.60%FY26 Revenue: ₹227.27 Cr
📅 Short termThe confirmation of the final dividend is likely to be viewed positively by retail investors in the coming days.
📈 Long termLimited structural impact as this was a routine AGM; however, the high dividend payout suggests management confidence in cash flows despite the capital-intensive nature of hospital expansions.
⚠ Risk flags
- Dividend payout exceeds FY26 earnings per share
- Multiple related-party remuneration approvals
Key Highlights
Final dividend of ₹1.50 (15%) declared, bringing total FY26 dividend to ₹2.50 per share
66 members attended the meeting, representing 65.60% of the company's shareholding
FY26 Audited Financial Statements adopted with a reported revenue of ₹227.27 Cr and PAT of ₹17.05 Cr
Shareholders voted on the re-appointment of Independent Directors Mr. Hari Modi and Dr. Tapti Sen
Approval sought for professional fees and remuneration for three related-party individuals (Dr. Mridul Tantia, Dr. Niharika Tantia, and Dr. Ghanshyam Goyal)
👀 What to Watch
Investors should monitor the final voting results to be published within 2 working days to confirm the approval of related-party remuneration and director re-appointments.
L&T Q1 FY27: PAT Up 14% to ₹4,123 Cr; Order Inflow Hits ₹1.08 Lakh Cr
L&T reported a strong start to FY27 with consolidated PAT rising 14% YoY to ₹4,123 crore. Revenue grew 7% YoY to ₹67,942 crore, with international markets contributing 51%. The company secured massive order inflows of ₹108,014 crore during the quarter, a 14% YoY increase, taking the total order book to a record ₹778,954 crore. Additionally, the board approved the merger of its wholly-owned subsidiary, L&T Power Development Limited, to simplify the corporate structure.
Confidence: HIGH
What changedL&T re-filed its Q1 FY27 results in a machine-readable format and formally initiated the merger of its power development subsidiary.
Why it mattersThe strong order inflow growth (14%) and record order book provide high revenue visibility, while the merger and divestment of Nabha Power/Hyderabad Metro signal a strategic exit from low-ROCE concession assets.
Q1 Consolidated Revenue: ₹67,942 croreQ1 Consolidated PAT: ₹4,123 croreOrder Inflow vs TTM Revenue: 37.8%Order Book vs TTM Revenue: 2.72xInternational Revenue Share: 51%
📅 Short termThe stock is likely to react positively to the double-digit PAT growth and the robust order inflow momentum despite global volatility.
📈 Long termStructural simplification through subsidiary mergers and the focus on high-tech manufacturing and green energy segments align with the 'Lakshya 2031' strategic plan for sustainable value creation.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Geopolitical uncertainties impacting international project timelines
- Potential cost overruns in legacy energy projects
Key Highlights
Consolidated PAT increased 14% YoY to ₹4,123 crore for the quarter ended June 30, 2026.
Order inflows reached ₹108,014 crore in Q1, representing approximately 38% of TTM revenue.
Total consolidated order book stands at ₹778,954 crore, providing 2.7x revenue visibility relative to TTM revenue.
International orders accounted for 56% of the quarterly inflow and 52% of the total order book.
Board approved the merger of L&T Power Development Limited (Net worth ₹2,703 crore) into the parent company.
👀 What to Watch
Investors should monitor the execution pace of the ₹7.79 trillion order book and the finalization of the Hyderabad Metro divestment to the Telangana Government.
TruAlt Bioenergy FY26 PAT Drops 34.6% to ₹96.87 Cr; AGM Scheduled for Aug 31, 2026
TruAlt Bioenergy has issued its FY26 Integrated Annual Report and scheduled its 5th AGM for August 31, 2026. The company reported a 9.45% decline in consolidated revenue to ₹1,727.51 cr and a sharp 34.57% drop in PAT to ₹96.87 cr for FY26. The decline was primarily driven by reduced ethanol lifting by OMCs and higher finance costs (₹160.02 cr) related to new grain-based plant debt. Despite the profit dip, the company successfully capitalized a 1,300 KLPD grain-based plant, increasing its total installed capacity to 2,000 KLPD.
Confidence: HIGH
What changedThe company has formalized its FY26 financial results and scheduled its AGM, confirming a significant year-on-year decline in profitability and revenue.
Why it mattersThe results highlight the company's vulnerability to government-controlled ethanol procurement and OMC lifting schedules, despite significant capacity additions in the grain-based segment.
Consolidated Revenue (FY26): ₹1,727.51 crConsolidated PAT (FY26): ₹96.87 crRevenue Growth (YoY): -9.45%PAT Growth (YoY): -34.57%Finance Cost (Consolidated): ₹160.02 crAGM Date: August 31, 2026
📅 Short termThe stock may experience negative sentiment in the short term as the market reacts to the audited decline in annual profits and revenue.
📈 Long termLong-term prospects depend on the successful scaling of the CBG vertical and SAF entry by FY28, alongside improved capacity utilization of the 1,300 KLPD dual-feed plant.
⚠ Risk flags
- Client concentration (OMCs)
- Regulatory risk regarding ethanol pricing and lifting
- Rising finance costs from debt-funded expansion
Key Highlights
Consolidated Revenue for FY26 decreased 9.45% YoY to ₹1,727.51 cr from ₹1,907.72 cr.
Consolidated Profit After Tax (PAT) fell 34.57% YoY to ₹96.87 cr, with EPS dropping to ₹12.30 from ₹20.94.
Finance costs rose to ₹160.02 cr due to additional working capital and interest on the new grain-based plant.
Installed capacity stands at 2,000 KLPD, with 1,300 KLPD recently converted to dual-feed capability.
Revenue was impacted by a pending 15 crore litre allocation following a Karnataka High Court order.
👀 What to Watch
Investors should monitor the resolution of the Karnataka High Court order regarding the 15 crore litre allocation and the stabilization of ethanol lifting by OMCs. The execution of the 17 planned CBG plants and the FY28 entry into the Sustainable Aviation Fuel (SAF) market are key long-term growth drivers to watch.
